NASDAQ : WGS
GeneDx Holdings Corp. — Company profile
Healthcare · Diagnostics & Research · United States
Last price 71.02 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 2.12B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Details
| Name | GeneDx Holdings Corp. |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Employees | 1300 |
| Founded | 2017 |
| Ceo | Katherine Stueland |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US81663L2007 |
| Cusip | 81663L200 |
| Cik | 1818331 |
| Sic | 8000 |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
Key executives
| Name | Title |
|---|---|
| Katherine A. Stueland | Chief Executive Officer and Director |
| Kevin Feeley CPA | Chief Financial Officer |
| Dr. Bryan M. Dechairo Ph.D. | Chief Technology and Innovation Officer |
| Mark A. Gardner M.B.A. | President |
| Sabrina V. Dunbar | Director of Investor Relations and Communications |
| Heidi C. Chen J.D. | Chief Legal Officer |
| Jami Biliboaca | Chief People Officer |
| Melanie Duquette | Chief Growth Officer |
| Lisa Gurry | Chief Business Officer |
| Linda Genen M.D., M.P.H. | Chief Medical Officer |
Contact
| Address | North Tower, 6th Floor, Stamford, Connecticut 06902, United States |
| Phone | 888 729 1206 |
| Website | https://www.genedx.com |